BioProgress plc ('BioProgress' or the 'Company')
(AIM: BPRG; NASDAQ: BPRG), the speciality pharma and healthcare company, today announces the appointment to the Board of Steve Martin as the Company's new Commercial Development Director with effect from 25 July 2006. Steve has been employed for the last nine months by BioProgress' subsidiary, Dexo BioPharm, as Director of Pharmaceuticals.
